Skip to main content
Clinical Trials/NCT03452956
NCT03452956
Completed
N/A

Cognitive Impairement In Frontotemporal Dementia

University of Pennsylvania1 site in 1 country997 target enrollmentJuly 1, 2003

Overview

Phase
N/A
Intervention
Not specified
Conditions
Frontotemporal Degeneration
Sponsor
University of Pennsylvania
Enrollment
997
Locations
1
Primary Endpoint
Progression
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatments.

Detailed Description

Comparative and longitudinal studies reveal clinical differences between subgroups of patients with frontotemporal dementia (FTD), including Progressive Non-fluent Aphasia (PNFA), Semantic Dementia (SD), patients with a disorder of social comportment and personality (SOC), and non-aphasic patients with executive dysfunction (EXEC). MRI studies of cortical atrophy and fMRI studies show correlated neural defects in FTD subgroups. The investigators will obtain converging evidence from multiple sources to test hypotheses about the neural basis for cognitive functions such as semantic memory, grammatical processing, and social functioning in these FTD subgroups, while improving clinical care for these patients. Recent studies have linked progressive supra nuclear palsy (PSP) and multiple systems atrophy (MSA) to FTD. The investigators will obtain comparable neuropsychological and biomarker data in order to compare these patient groups.

Registry
clinicaltrials.gov
Start Date
July 1, 2003
End Date
July 15, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Individuals who have been diagnosed with FTD, PSP, and MSA

Exclusion Criteria

  • Individuals under 18 years of age
  • People with pacemakers or certain metallic implants
  • pregnant women

Outcomes

Primary Outcomes

Progression

Time Frame: This is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passed

Changes over time in MRI and cognitive testing data.

Secondary Outcomes

  • Impaired semantic memory in Semantic Dementia (SD).(This is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passed)

Study Sites (1)

Loading locations...

Similar Trials